Psyence Biomedical Adds Intraday Equity Purchase Option in White Lion Financing Deal
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Psyence Biomedical ( (PBM) ) is now available.
On April 19, 2026, Psyence Biomedical amended its existing Common Stock Purchase Agreement with White Lion Capital to introduce an intraday purchase mechanism for its common shares, allowing the company to issue Intraday Purchase Notices during the commitment period for share sales capped at 5% of average daily trading volume. Under this structure, White Lion must consent within 15 minutes, the purchase price is set at the lowest traded price in the following one-hour valuation window subject to a floor, settlement occurs within two business days, and Psyence receives a $22,000 legal preparation fee, enhancing its flexibility in timing and structuring equity raises while the broader agreement otherwise remains in force.
The change also updates key contractual definitions to include the new Intraday Purchase Notice form and clarifies that White Lion may contract for resales of purchased shares during specified valuation periods without such activity being deemed short selling. This adjustment is expected to give Psyence more responsive access to capital markets and potentially improve its ability to manage funding needs and trading dynamics, while keeping the core financing relationship with White Lion intact as of the April 20, 2026 filing date.
More about Psyence Biomedical
Psyence Biomedical Ltd. is a Toronto-based life sciences company operating as a foreign private issuer on U.S. markets, with its common shares actively traded and subject to a structured equity purchase facility. The company raises capital through a Common Stock Purchase Agreement with institutional investor White Lion Capital, reflecting a financing model geared to accessing public market liquidity.
Average Trading Volume: 207,494
Technical Sentiment Signal: Sell
Current Market Cap: $2.94M
For a thorough assessment of PBM stock, go to TipRanks’ Stock Analysis page.
